Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback